Tieӧs Pharmaceuticals, a bioscience company based in Moncton, has been chosen by national industry association BIOTECanada as one of four competitors in the Coast to Coast Competition to be held at the 2019 BIO International Convention and Trade Show.
The show is the world’s largest bioscience convention, drawing more than 16,000 attendees. This year’s event is taking place in Philadelphia and is being attended by leaders of Atlantic Canada’s bioscience sector.
Tieӧs has partnered with Cyclica, a Toronto company that applies artificial intelligence to medical research, to help in creating new classes of medications for treating cancer.
The two companies use artificial intelligence algorithms and computational biology to create “polypharmacological compounds”, which are drugs that act on several disease pathways at once. Tieös aims to simultaneously attack cancer tumors in various ways, while using intelligent design elements to minimize drug resistance and collateral damage.
The company will present to a panel of life science investors in the Canada Pavilion on June 5 with the hope of winning a presentation spot during BIOTECanada’s Investor Summit to be held in Whistler in March 2020.
This week, the bioscience sectors of all four Atlantic provinces are being promoted by the Atlantic Canada Bio-Industries Alliance. The region’s sector employs more than 3,000 workers and represents $655 million in revenue from upward of 200 companies and at least 50 research organizations, participants said in a statement.
The provinces have developed complementary strengths, the statement said. In Newfoundland, marine biotechnology and human genomics dominate. In New Brunswick, the focus is agriculture and bio-resources. In Nova Scotia, it is marine, health, bio-medical and general biotechnology. On PEI, strengths are pharmaceutical manufacturing, diagnostics, natural health products and animal and fish health.
Official delegates of the Atlantic Canadian mission include representatives from each of the following:
Appili Therapeutics
Atlantic Cancer Research Institute
BioMedica Diagnostics Inc.
BioNova
BioVectra
Center for Aquaculture Technologies
Dosecann
Government of New Brunswick
Innovation PEI
New Brunswick Institute for Research, Data and Training (NB-IRDT)
New Brunswick Health Research Foundation
Neurodyn Cognition Inc.
PEI BioAlliance
PhotoDynamic Inc.
Sequence Bio
Tieos Pharmaceuticals
Torigen Pharmaceuticals, Inc.
Université de Moncton
VetNOW – One Health Solutions
Vitalité Health Network
Funding support for the mission is provided by the Atlantic Canada Opportunities Agency and the four Atlantic provincial governments through the Atlantic Trade and Investment Growth Strategy.
The Atlantic Canadian mission was coordinated by the PEI BioAlliance, on behalf of the Atlantic Canada Bio-Industries Alliance. The alliance comprises BioNB, BioNova, the Newfoundland & Labrador Association of Technology Industries and the PEI BioAlliance.
